The Diabetic Phenotype Is Conserved in Myotubes Established From Diabetic Subjects

Evidence for Primary Defects in Glucose Transport and Glycogen Synthase Activity

  1. Michael Gaster,
  2. Ingrid Petersen,
  3. Kurt Højlund,
  4. Pernille Poulsen and
  5. Henning Beck-Nielsen
  1. From the Department of Endocrinology, Odense University Hospital, Odense, Denmark

    Abstract

    The most well-described defect in the pathophysiology of type 2 diabetes is reduced insulin-mediated glycogen synthesis in skeletal muscles. It is unclear whether this defect is primary or acquired secondary to dyslipidemia, hyperinsulinemia, or hyperglycemia. We determined the glycogen synthase (GS) activity; the content of glucose-6-phosphate, glucose, and glycogen; and the glucose transport in satellite cell cultures established from diabetic and control subjects. Myotubes were precultured in increasing insulin concentrations for 4 days and subsequently stimulated acutely by insulin. The present study shows that the basal glucose uptake as well as insulin-stimulated GS activity is reduced in satellite cell cultures established from patients with type 2 diabetes. Moreover, increasing insulin concentrations could compensate for the reduced GS activity to a certain extent, whereas chronic supraphysiological insulin concentrations induced insulin resistance in GS and glucose transport activity. Our data suggest that insulin resistance in patients with type 2 diabetes comprises at least two important defects under physiological insulin concentrations: a reduced glucose transport under basal conditions and a reduced GS activity under acute insulin stimulation, implicating a reduced glucose uptake in the fasting state and a diminished insulin-mediated storage of glucose as glycogen after a meal.

    Footnotes

    • Address correspondence and reprint requests to Michael Gaster, MD, PhD, Department of Endocrinology, Odense University Hospital, DK-5000 Odense, Denmark. E-mail (secretary): janne.dyhr{at}ouh.dk.

      Received for publication 24 August 2001 and accepted in revised form 8 January 2002.

      DMEM, Dulbecco’s modified Eagle’s medium; DOG, 2-deoxyglucose; FV, fractional velocity; G6P, glucose-6-phosphate; GS, glycogen synthase; Sc, satellite cells.

    « Previous | Next Article »Table of Contents